Zhang et al87 found that a GABAAR agonist named muscimol can inhibit the activation and proliferation of tumor‐infiltrating CD8+ T cells, whereas the GABAAR antagonist picrotoxin can promote the cytotoxic activity of CD8+ T cells and limit tumor growth in vivo. Here, CD8A is linked to neoplasm.